Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

If We Build It, Will They Come? A Pilot Study to Develop and Test Messages to Maximize Uptake of Coronavirus Vaccine When Available

NCT04706403 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT04706403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
If We Build It, Will They Come? A Pilot Study to Develop and Test Messages to Maximize Uptake of Coronavirus Vaccine When Available
Lead sponsor
University of Massachusetts, Worcester
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2021
Completion date
February 1, 2021
Enrollment
756 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19